Literature DB >> 12897847

The complex interactions of p53 with target DNA: we learn as we go.

Ella Kim1, Wolfgang Deppert.   

Abstract

The most import biological function of the tumor suppressor p53 is that of a sequence-specific transactivator. In response to a variety of cellular stress stimuli, p53 induces the transcription of an ever-increasing number of target genes, leading to growth arrest and repair, or to apoptosis. Long considered as a "latent" DNA binder that requires prior activation by C-terminal modification, recent data provide strong evidence that the DNA binding activity of p53 is strongly dependent on structural features within the target DNA and is latent only if the target DNA lacks a certain structural signal code. In this review we discuss evidence for complex interactions of p53 with DNA, which are strongly dependent on the dynamics of DNA structure, especially in the context of chromatin. We provide a model of how this complexity may serve to achieve selectivity of target gene regulation by p53 and how DNA structure in the context of chromatin may serve to modulate p53 functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897847     DOI: 10.1139/o03-046

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  13 in total

1.  The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.

Authors:  Andrei L Okorokov; Michael B Sherman; Celia Plisson; Vera Grinkevich; Kristmundur Sigmundsson; Galina Selivanova; Jo Milner; Elena V Orlova
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

2.  Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.

Authors:  Elizabeth Turpin; Kimberly Luke; Jeremy Jones; Terrence Tumpey; Kouacou Konan; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 3.  Mutant p53: one name, many proteins.

Authors:  William A Freed-Pastor; Carol Prives
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

Review 4.  Cruciform structures are a common DNA feature important for regulating biological processes.

Authors:  Václav Brázda; Rob C Laister; Eva B Jagelská; Cheryl Arrowsmith
Journal:  BMC Mol Biol       Date:  2011-08-05       Impact factor: 2.946

5.  Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.

Authors:  Lars O Baumbusch; Simen Myhre; Anita Langerød; Anna Bergamaschi; Stephanie B Geisler; Per E Lønning; Wolfgang Deppert; Irene Dornreiter; Anne-Lise Børresen-Dale
Journal:  Mol Cancer       Date:  2006-10-20       Impact factor: 27.401

6.  Mutant p53 proteins bind DNA in a DNA structure-selective mode.

Authors:  Thomas Göhler; Stefan Jäger; Gabriele Warnecke; Hideyo Yasuda; Ella Kim; Wolfgang Deppert
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

Review 7.  DNA and RNA quadruplex-binding proteins.

Authors:  Václav Brázda; Lucia Hároníková; Jack C C Liao; Miroslav Fojta
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

8.  p53 Specifically Binds Triplex DNA In Vitro and in Cells.

Authors:  Marie Brázdová; Vlastimil Tichý; Robert Helma; Pavla Bažantová; Alena Polášková; Aneta Krejčí; Marek Petr; Lucie Navrátilová; Olga Tichá; Karel Nejedlý; Martin L Bennink; Vinod Subramaniam; Zuzana Bábková; Tomáš Martínek; Matej Lexa; Matej Adámik
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Correlated evolution of positions within mammalian cis elements.

Authors:  Rithun Mukherjee; Perry Evans; Larry N Singh; Sridhar Hannenhalli
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.